why choose us

First received: November 30, 2022

Clinical Trial: Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders

Study Status: Completed

Recruit Status: RECRUITING

Condition: Mood Disorders

Study Type: INTERVENTIONAL


Official Title: A New Intervention for Implementation of Pharmacogenetics in Psychiatry

Brief Summary: A 24-week, patient- and rater-blinded, two-arm, parallel-group controlled, and multi-centre randomized clinical trial (RCT) to establish the benefits of pharmacogenetics-informed pharmacotherapy versus dosing as usual (DAU) in psychiatric patients suffering from mood, anxiety, or psychotic disorders.

Read more